Increasing Vaccine Reach in China
Pfizer is committed to supporting comprehensive tobacco control measures to prevent the development of future generations of smokers, to encourage and enable smokers to quit, and to help former smokers remain smoke free
Bringing Xeljanz® to More Patients Worldwide
Advancing Care Worldwide for People Living With Eczema
Emerging Markets
Ibrance® Receives Approval in China
"The imbalance of health care around the world is astounding. The continent of Africa bears almost 25 percent of the global burden of disease yet has access to only 3 percent of its health workers and only 1 percent of its financial resources. We need more people, with and without medical skills, who are willing to commit their creative minds to address patients' needs."
Innovating to Advance Global Health Access
Combating the Tobacco Epidemic at a Global Level
Pfizer Deepens Scientific Knowledge to Create More Options for Autoimmune Patients
A Landmark Year in Pfizer's Quest to Change the Trajectory of Cancer
"Even with the significant improvements observed across biomarker-driven non-small cell lung cancer, we are reminded every day of the great need for new treatment options that may benefit patients with these types of lung cancers"
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families